Viability of Plasmodium falciparum parasites in human plasma under different storage conditions
- PMID: 39663764
- DOI: 10.1111/vox.13781
Viability of Plasmodium falciparum parasites in human plasma under different storage conditions
Abstract
Background and objectives: Malaria risk deferral policies are important for mitigating the risk of transfusion-transmitted malaria and apply to all transfusable components, including plasma. While donors of plasma components are deferred for malaria risk in the United States, the viability of intraerythrocytic Plasmodium falciparum parasites present in human plasma components stored under different temperatures and durations has not been previously reported.
Materials and methods: We spiked human plasma with a low level of ring-stage P. falciparum-infected red blood cells and then determined their viability in cultures after storage at room temperature (22°C), refrigeration (4°C) and frozen conditions at -20 and -80°C.
Results: P. falciparum parasites spiked in human plasma remained viable after storage at 22°C for a maximum of 7 days. When stored at 4°C, parasites were viable after 1 and 3 days of storage and only for 1 day after storage at -20°C. Storage at -80°C had a cryopreserving effect and parasites remained viable for up to 176 days, the longest period tested.
Conclusion: P. falciparum parasites can survive for short durations in human plasma when stored at room temperature, or in refrigerated or frozen conditions at -20°C. However, when stored at -80°C, viable parasites were detected for up to 176 days, the maximum duration for which viability was assessed. In summary, Plasmodium parasites can survive in human plasma under different storage conditions and pose a risk of transfusion-transmitted infection.
Keywords: Plasmodium falciparum; donor deferral; human plasma; transfusion‐transmitted malaria.
Published 2024. This article is a U.S. Government work and is in the public domain in the USA.
References
REFERENCES
-
- WHO. World Malaria Report 2023. Available URL: https://iris.who.int/bitstream/handle/10665/374472/9789240086173‐eng.pdf. Last accessed Dec 6, 2024.
-
- Mace KE, Lucchi NW, Tan KR. Malaria surveillance—United States, 2018. MMWR Surveill Summ. 2022;71:1–35.
-
- Selover C, Thacker C, Hill M, Lugo F, Lo M, Pawlowicz M, et al. Multifocal autochthonous transmission of malaria—Florida, 2003. MMWR Morb Mortal Wkly Rep. 2004;53:412–414.
-
- Blackburn D, Drennon M, Broussard K, Morrison AM, Stanek D, Sarney E, et al. Outbreak of locally acquired mosquito‐transmitted (autochthonous) malaria—Florida and Texas, May‐July 2023. MMWR Morb Mortal Wkly Rep. 2023;72:973–978.
-
- Duwell M, DeVita T, Chen J, Myers RA, Mace K, Ridpath AD, et al. Locally acquired mosquito‐transmitted (autochthonous) Plasmodium falciparum malaria—National Capital Region, Maryland, August 2023. MMWR Morb Mortal Wkly Rep. 2023;72:1123–1125.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources